CompletedPHASE2, PHASE3NCT00441285
Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ)
Studying Cysticercosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Universidad Peruana Cayetano Heredia
- Principal Investigator
- Hector H. Garcia, MDUniversidad Peruana Cayetano Heredia
- Intervention
- Praziquantel(drug)
- Enrollment
- 156 enrolled
- Eligibility
- 16-65 years · All sexes
- Timeline
- 2010 – 2013
Study locations (5)
- Hospital Nacional Edgardo Rebagliati, Lima, Lima Province, Peru
- Hospital Nacional Cayetano Heredia, Lima, Lima Province, Peru
- Hospital Nacional Guillermo Almenara, Lima, Lima Province, Peru
- Instituto Nacional de Ciencias Neurologicas, Lima, Peru
- Universidad Peruana Cayetano Heredia, Lima, Peru
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00441285 on ClinicalTrials.govOther trials for Cysticercosis
Additional recruiting or active studies for the same condition.